Immune Pressure? Sporozoite Vaccine Candidate, Selected by Circumsporozoite Antigen, a Leading Plasmodium falciparum in the Are Extensive T Cell Epitope Polymorphisms

Protective cellular immune responses depend on MHC presentation of pathogen-derived Ag fragments. MHC diversity renders this process sensitive to point mutations coding for altered amino acid sequence of the short target Ag-derived peptides epitopes. Thus, in a given host, a pathogen with an altered epitope sequence will be more likely to escape detection and elimination by the immune system. At a population level, selection by immune pressure will increase the likelihood of polymorphism in important pathogen antigenic epitopes. This mechanism of immune evasion is found in viruses and other pathogens. The detection of polymorphic hot spots in an Ag is often taken as a strong indication of its role in protective immunity. We provide evidence that polymorphisms in the T cell epitopes of a malaria vaccine candidate are unlikely to have been selected by immune pressure in the human host. The Journal of Immunology, 2005, 175: 3935–3939. originating from Ratchaburi and Kanchanburi, as described above. The polymorphic regions present in three unlinked single-copy P. falciparum genes were as follows: block 2 of the merozoite surface protein 1 ( msp1 ), block 3 of the merozoite surface protein 2 ( msp2 and the RII region of the glutamate rich protein ( glurp ) were amplified according to a previously published nested PCR protocol (11). The products were electrophoresed 3% DNA was visualized an UV transil- luminator ethidium bromide Fragment of highest genetic

[1]  Inacio Mandomando,et al.  Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial , 2004, The Lancet.

[2]  L. Rénia,et al.  A survey of the Th2R and Th3R allelic variants in the circumsporozoite protein gene of P. falciparum parasites from western Thailand. , 2004, The Southeast Asian journal of tropical medicine and public health.

[3]  A. Hill,et al.  A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease , 2004, Nature Medicine.

[4]  L. Rénia,et al.  Pre-erythrocytic antigens of Plasmodium falciparum: from rags to riches? , 2003, Trends in parasitology.

[5]  D. Conway,et al.  Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. , 2003, The American journal of tropical medicine and hygiene.

[6]  S. Kariuki,et al.  A study of genetic diversity in the gene encoding the circumsporozoite protein (CSP) of Plasmodium falciparum from different transmission areas--XVI. Asembo Bay Cohort Project. , 2002, Molecular and biochemical parasitology.

[7]  D. Conway,et al.  Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial , 2001, The Lancet.

[8]  D. Conway,et al.  High-throughput sequence typing of T-cell epitope polymorphisms in Plasmodium falciparum circumsporozoite protein. , 2000, Molecular and biochemical parasitology.

[9]  T. McCutchan,et al.  The Cytotoxic T-Lymphocyte Epitope of the Plasmodium falciparum Circumsporozoite Protein Also Modulates the Efficiency of Receptor-Ligand Interaction with Hepatocytes , 2000, Infection and Immunity.

[10]  M. Plebanski,et al.  Induction of CD8+ T cells using heterologous prime‐boost immunisation strategies , 1999, Immunological reviews.

[11]  W. Jarra,et al.  Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[12]  K. Kain,et al.  Differential Susceptibilities of Anopheles albimanus and Anopheles pseudopunctipennis to Infections with Coindigenous Plasmodium vivaxVariants VK210 and VK247 in Southern Mexico , 1999, Infection and Immunity.

[13]  A. Hill,et al.  Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. , 1997, Journal of immunology.

[14]  R. Ménard,et al.  Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes , 1997, Nature.

[15]  R. Paru,et al.  Mating patterns in malaria parasite populations of Papua New Guinea. , 1995, Science.

[16]  A. Hughes,et al.  Allelic variation in the circumsporozoite protein of Plasmodium falciparum from Thai field isolates. , 1994, The American journal of tropical medicine and hygiene.

[17]  V. Nussenzweig,et al.  Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes , 1993, The Journal of experimental medicine.

[18]  D. Doolan,et al.  Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development , 1992, Infection and immunity.

[19]  V. Nussenzweig,et al.  Plasmodium falciparum: restricted polymorphism of T cell epitopes of the circumsporozoite protein in Brazil. , 1990, Experimental parasitology.

[20]  C. Newbold,et al.  Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein. , 1989, Molecular and biochemical parasitology.

[21]  T. McCutchan,et al.  Polymorphism in the circumsporozoite (CS) protein of Plasmodium falciparum. , 1989, Parasitology today.

[22]  V. Nussenzweig,et al.  Rationale for the development of an engineered sporozoite malaria vaccine. , 1989, Advances in immunology.

[23]  M. J. Stewart,et al.  Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility. , 1988, The Journal of protozoology.

[24]  J. Berzofsky,et al.  Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Miller,et al.  The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation. , 1988, Immunology today.

[26]  L. Rozeboom,et al.  On the Comparative Susceptibility of Certain Species of Nearctic and Neotropical Anophelines to Certain Strains of P. Vivax and P. Falciparum from the Same Regions1 , 1938 .

[27]  S. P. James,et al.  A Study of Induced Malignant Tertian Malaria , 1932, The Indian medical gazette.